Recombinant CD6 (Itolizumab Biosimilar) antibody
Quick Overview for Recombinant CD6 (Itolizumab Biosimilar) antibody (ABIN7487955)
Target
Antibody Type
Reactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Itolizumab Biosimilar - Anti-CD6 mAb
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- CD6 (Itolizumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
T1h
Itolizumab is investigated for the treatment of patients Hospitalized With COVID-19. -
CAS-No
- 1116433-11-4
Target
-